Explanation for the Decline in Coronary Heart Disease Mortality Rates in Auckland, New Zealand, Between 1982 and 1993
- 26 September 2000
- journal article
- other
- Published by Wolters Kluwer Health in Circulation
- Vol. 102 (13) , 1511-1516
Abstract
Background —We sought to determine how much of the recent, substantial fall in coronary heart disease (CHD) mortality rates in New Zealand can be attributed to “evidence-based” medical and surgical treatments and how much can be attributed to cardiovascular risk factor reductions. Methods and Results —A cell-based mortality model was developed and refined. This model combined (1) the published effectiveness of cardiological treatments and risk factor reductions with (2) data on all medical and surgical treatments administered to all CHD patients and (3) trends in population cardiovascular risk factors (principally smoking, cholesterol, and hypertension) from 1982 to 1993 in Auckland, New Zealand (population 996 000). Between 1982 and 1993, CHD mortality rates fell by 23.6%, with 671 fewer CHD deaths than expected from baseline mortality rates in 1982. Forty-six percent of this fall was attributed to treatments (acute myocardial infarction 12%, secondary prevention 12%, hypertension 7%, heart failure 6%, and angina 9%), and 54% was attributed to risk factor reductions (smoking 30%, cholesterol 12%, population blood pressure 8%, and other, unidentified factors 4%). These proportions remained relatively consistent after a robust sensitivity analysis. Conclusions —Approximately half the CHD mortality rate fall in Auckland, New Zealand, was attributed to medical therapies, and approximately half was attributed to reductions in major risk factors. These findings emphasize the importance of a comprehensive strategy that maximizes the population coverage of effective treatments and actively promotes a prevention program, particularly for smoking, diet, and blood pressure reduction.Keywords
This publication has 27 references indexed in Scilit:
- Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populationsThe Lancet, 2000
- Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994Heart, 1999
- Mortality by cause for eight regions of the world: Global Burden of Disease StudyThe Lancet, 1997
- Evidence-based medicine and treatment choicesThe Lancet, 1997
- Recent Trends in Acute Coronary Heart Disease — Mortality, Morbidity, Medical Care, and Risk FactorsNew England Journal of Medicine, 1996
- Changes in risk factors explain changes in mortality from ischaemic heart disease in FinlandBMJ, 1994
- Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patientsBMJ, 1994
- Decline in ischaemic heart disease in Iceland and change in risk factor levels.BMJ, 1991
- Trends in Coronary Heart Disease Mortality and Morbidity in Auckland, New Zealand, 1974–1986International Journal of Epidemiology, 1990
- Medical management and the decline in mortality from coronary heart disease.BMJ, 1986